Showing 1 - 15 results of 15 for search 'Yasutomo Imai', query time: 0.04s
Refine Results
-
1
-
2
Alarmins/stressorins and immune dysregulation in intractable skin disorders by Kiyofumi Yamanishi, Yasutomo Imai
Published 2021-10-01
Article -
3
-
4
Dupilumab treatment reduces serum SCCA2 levels in patients with atopic dermatitis by Kanako Kita, Yasutomo Imai, Makoto Nagai, Masaru Natsuaki, Nobuo Kanazawa
Published 2023-06-01
Article -
5
-
6
Long-term Remission of Atopic Dermatitis after Discontinuation of Dupilumab by Shoko Miyamoto, Yasutomo Imai, Masaru Natsuaki, Kiyofumi Yamanishi, Nobuo Kanazawa
Published 2022-06-01
Article -
7
-
8
-
9
-
10
-
11
-
12
-
13
Monitoring Cellular Movement with Photoconvertible Fluorescent Protein and Single-Cell RNA Sequencing Reveals Cutaneous Group 2 Innate Lymphoid Cell Subtypes, Circulating ILC2 and... by Minori Nakatani-Kusakabe, Koubun Yasuda, Michio Tomura, Makoto Nagai, Kiyofumi Yamanishi, Etsushi Kuroda, Nobuo Kanazawa, Yasutomo Imai
Published 2021-09-01
Article -
14
Evaluation of long‐term disease control with dupilumab therapy using the Atopic Dermatitis Control Tool in real‐world clinical practice by Marin Kunimoto, Yasutomo Imai, Masako Matsutani, Minori Nakatani‐Kusakabe, Makoto Nagai, Masaru Natsuaki, Kiyofumi Yamanishi, Nobuo Kanazawa
Published 2022-04-01
Article -
15
Immune-checkpoint protein VISTA critically regulates the IL-23/IL-17 inflammatory axis by Na Li, Wenwen Xu, Ying Yuan, Natarajan Ayithan, Yasutomo Imai, Xuesong Wu, Halli Miller, Michael Olson, Yunfeng Feng, Yina H. Huang, Mary Jo Turk, Samuel T. Hwang, Subramaniam Malarkannan, Li Wang
Published 2017-05-01
Article